Cmc And Spike Human

Lab Reagents

Human IgG antibody Laboratories manufactures the cmc and spike human reagents distributed by Genprice. The Cmc And Spike Human reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Human. Other Cmc products are available in stock. Specificity: Cmc Category: And Group: Spike Human

Spike Human information

SARS Spike Antibody

24318-100ul 100ul
EUR 468

SARS Spike Peptide

3525P 0.05 mg
EUR 197.7
Description: (CT) SARS Spike peptide

SARS Spike Antibody

20-abx137184
  • EUR 1262.40
  • EUR 1846.80
  • EUR 2064.00
  • 100 ug
  • 200 ug
  • 300 µg

SARS Spike Antibody

20-abx137200
  • EUR 1412.40
  • EUR 2264.40
  • EUR 2665.20
  • 100 ug
  • 200 ug
  • 300 µg

Spike Glycoprotein Antibody

20-abx300551
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Acids Matrix Spike

CLPS-MSA 1ML
EUR 120.84

TCLP Volatiles Spike

TCLP-VX 1ML
EUR 106.02

CLP ILM 02.0

SPIKE-1 125ML
EUR 303.24

Human coronavirus OC43 Spike glycoprotein (S)

1-CSB-YP336163HIY
  • EUR 516.00
  • EUR 280.80
  • EUR 1809.60
  • EUR 770.40
  • EUR 1210.80
  • EUR 349.20
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human coronavirus OC43 Spike glycoprotein(S) ,partial expressed in Yeast

Human coronavirus OC43 Spike glycoprotein (S)

1-CSB-EP336163HIY
  • EUR 456.00
  • EUR 256.80
  • EUR 1570.80
  • EUR 672.00
  • EUR 1047.60
  • EUR 314.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human coronavirus OC43 Spike glycoprotein(S) ,partial expressed in E.coli

Recombinant SARS-CoV-2 Spike S1 Protein with hFc and His-Tag

E80001-1 100 ul
EUR 518.1

Recombinant SARS-CoV-2 Spike S1 Protein with His and Avi Tag

E80003-1 100 ul
EUR 518.1

SARS-CoV Spike Antibody

3219-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody

3219-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody

3221-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody

3221-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS (IN1) Spike Peptide

3221P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN1) Spike peptide